These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26773569)

  • 1. Evolving insights into the synergy between erythropoietin and thrombopoietin and the bipotent erythroid/megakaryocytic progenitor cell.
    Papayannopoulou T; Kaushansky K
    Exp Hematol; 2016 Aug; 44(8):664-8. PubMed ID: 26773569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the cellular mechanisms of erythropoietin-thrombopoietin synergy.
    Papayannopoulou T; Brice M; Farrer D; Kaushansky K
    Exp Hematol; 1996 Apr; 24(5):660-9. PubMed ID: 8605971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of hematopoietic lineage-specific gene expression by ES cell in vitro differentiation induction system.
    Era T; Takagi T; Takahashi T; Bories JC; Nakano T
    Blood; 2000 Feb; 95(3):870-8. PubMed ID: 10648398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch Stimulates Both Self-Renewal and Lineage Plasticity in a Subset of Murine CD9High Committed Megakaryocytic Progenitors.
    Weiss-Gayet M; Starck J; Chaabouni A; Chazaud B; Morlé F
    PLoS One; 2016; 11(4):e0153860. PubMed ID: 27089435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparameter analysis of timelapse imaging reveals kinetics of megakaryocytic erythroid progenitor clonal expansion and differentiation.
    Scanlon VM; Thompson EN; Lawton BR; Kochugaeva M; Ta K; Mayday MY; Xavier-Ferrucio J; Kang E; Eskow NM; Lu YC; Kwon N; Laumas A; Cenci M; Lawrence K; Barden K; Larsuel ST; Reed FE; Peña-Carmona G; Ubbelohde A; Lee JP; Boobalan S; Oppong Y; Anderson R; Maynard C; Sahirul K; Lajeune C; Ivathraya V; Addy T; Sanchez P; Holbrook C; Van Ho AT; Duncan JS; Blau HM; Levchenko A; Krause DS
    Sci Rep; 2022 Sep; 12(1):16218. PubMed ID: 36171423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis of erythroid precursors under stimulation with thrombopoietin: contribution to megakaryocytic lineage choice.
    Sawai N; Koike K; Ito S; Kurokawa Y; Mwamtemi HH; Kinoshita T; Sakashita K; Higuchi T; Takeuchi K; Shiohara M; Ogami K; Komiyama A
    Stem Cells; 1999; 17(1):45-53. PubMed ID: 10215401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TEL/ETV6 accelerates erythroid differentiation and inhibits megakaryocytic maturation in a human leukemia cell line UT-7/GM.
    Takahashi W; Sasaki K; Kvomatsu N; Mitani K
    Cancer Sci; 2005 Jun; 96(6):340-8. PubMed ID: 15958056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate.
    Grover A; Mancini E; Moore S; Mead AJ; Atkinson D; Rasmussen KD; O'Carroll D; Jacobsen SE; Nerlov C
    J Exp Med; 2014 Feb; 211(2):181-8. PubMed ID: 24493804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fate Determination Role of Erythropoietin and Romiplostim in the Lineage Commitment of Hematopoietic Progenitors.
    Fan X; Krzyzanski W; Wong RSM; Yan X
    J Pharmacol Exp Ther; 2022 Jul; 382(1):31-43. PubMed ID: 35489782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mpl-ligand is involved in the growth-promoting activity of the murine stromal cell line MS-5 on ES cell-derived hematopoiesis.
    Mitjavila MT; Filippi MD; Cohen-Solal K; Le Pesteur F; Vainchenker W; Sainteny F
    Exp Hematol; 1998 Feb; 26(2):124-34. PubMed ID: 9472802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential amplification of murine bipotent megakaryocytic/erythroid progenitor and precursor cells during recovery from acute and chronic erythroid stress.
    Sanchez M; Weissman IL; Pallavicini M; Valeri M; Guglielmelli P; Vannucchi AM; Migliaccio G; Migliaccio AR
    Stem Cells; 2006 Feb; 24(2):337-48. PubMed ID: 16144876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
    Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective modulation of specific protein kinase C (PKC) isoforms in primary human megakaryocytic vs. erythroid cells.
    Marchisio M; Bertagnolo V; Celeghini C; Vitale M; Capitani S; Zauli G
    Anat Rec; 1999 May; 255(1):7-14. PubMed ID: 10321988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombopoietin has a differentiative effect on late-stage human erythropoiesis.
    Liu W; Wang M; Tang DC; Ding I; Rodgers GP
    Br J Haematol; 1999 May; 105(2):459-69. PubMed ID: 10233422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative and differentiative potential of thrombopoietin-responsive precursors: expression of megakaryocytic and erythroid lineages.
    Higuchi T; Koike K; Sawai N; Koike T
    Exp Hematol; 1997 Jun; 25(6):463-70. PubMed ID: 9197322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice.
    Kaushansky K; Lin N; Grossmann A; Humes J; Sprugel KH; Broudy VC
    Exp Hematol; 1996 Feb; 24(2):265-9. PubMed ID: 8641351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro autonomous growth of megakaryocytic progenitors and the role of thrombopoietin (Tpo) in essential thrombocythemia].
    Li Y; Brière J; Zhai M
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jun; 22(6):300-2. PubMed ID: 11877088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of signal transducer and activator of transcription 5 (STAT5) in CD34+ cells promotes megakaryocytic development, whereas activation of STAT5 drives erythropoiesis.
    Olthof SG; Fatrai S; Drayer AL; Tyl MR; Vellenga E; Schuringa JJ
    Stem Cells; 2008 Jul; 26(7):1732-42. PubMed ID: 18436865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flt3/Flk-2-ligand in synergy with thrombopoietin delays megakaryocyte development and increases the numbers of megakaryocyte progenitor cells in serum-free cultures initiated with CD34+ cells.
    Sigurjónsson OE; Gudmundsson KO; Haraldsdóttir V; Rafnar T; Gudmundsson S
    J Hematother Stem Cell Res; 2002 Apr; 11(2):389-400. PubMed ID: 11983110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.